In Brief: Guidant/Nucletron BV
This article was originally published in The Gray Sheet
Executive Summary
Guidant/Nucletron BV: Firms enter agreement to develop and distribute coronary radiation therapy devices to treat restenosis. The agreement builds on an April pact for development of catheter-based technology to deliver gamma radiation to help prevent restenosis of peripheral arteries ("The Gray Sheet" May 12, I&W-2)...